N/A(healthy adults)
Conditions
Interventions
Sponsors
Morinaga & Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Japanese individuals aged 30-59 years. 2)Individuals who are healthy without chronic physical illness, including skin diseases. 3)Individuals who are anxious about skin deterioration (dry or sagging skin, etc.) with aging. 4)Individuals whose written informed consent has been obtained. 5)Individuals who can visit an inspection facility and be inspected in designated days. 6)Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: 1)Individuals using medical products. 2)Individuals having or treated skin disease symptoms. 3)Individuals with strange skin conditions at assessed areas. 4)Individuals having a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 5)Individuals who contract or have a history of serious gastrointestinal disease. 6)Individuals with alcoholism or a mental illness. 7)Individuals who used or applied a drug for treatment of disease in the past 1 month. 8)Individuals with probable seasonal allergy during the test. 9)Individuals with food allergy. 10)Individuals with serious anemia. 11)Individuals who are a smoker. 12)Females who are or are possibly pregnant or lactating. 13)Males who usually shave with a razor. 14)Individuals whose life style will change during the test. 15)Individuals who will get sunburned during the test. 16)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements containing ingredients of the test food in the past 3 months or will ingest them during the test. 17)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements with the function of improving skin condition in the past 3 months or will ingest them during the test. 18)Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. 19)Individuals who conducted hormone replacement therapy in the past 6 months. 20)Individuals who have received a cosmetic medicine in the past 6 months. 21)Individuals hospitalized and received treatment in the past 6 months. 22)Individuals who participated in other clinical studies within one month of consent in this study or plan to participate. 23)Individuals having not completed two doses of COVID-19 vaccine. 24)Individuals planning to receive medication or vaccination during the test. 25)Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indexes for skin conditions (0, 8 weeks after ingestion) | — |
Countries
Japan
Contacts
Public ContactEriko Saito
Morinaga & Co., Ltd. Health Science and Research Center, R&D institute
Outcome results
None listed